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Abstract Mammary epithelial cells go through a series of
developmental changes during pregnancy and lactation
including proliferation, differentiation, secretion and apo-
ptosis. HC11 mouse mammary epithelial cells, which un-
dergo lactogen-induced differentiation in cell culture, were
used to follow the changes in gene expression during this
process. The expression profiles of over 20,000 genes were
compared in HC11 cells undergoing lactogenic differenti-
ation to non-differentiated cells using DNA microarray
analysis. Greater than two fold changes were detected in
998 genes in the differentiated cells versus growth controls.
Several genes including CTGF/CCN2 exhibited greater
than five-fold increase. Validation of the gene expression
patternformorethantwentygeneswasperformed.Theresults
indicate the involvement of numerous genes and pathways in
the differentiation of mouse mammary epithelial cells in
culture and they identify genetic pathways associated with
specific transcriptional regulation. In addition, the expression
of a subset of genes regulated by lactogenic differentiation in
HC11 cells, including CTGF/CCN2 and osteopontin, was
examined in mouse mammary glands revealing expression
during pregnancy and lactation that declined during involu-
tion of the glands. To probe the mechanism by which
epidermal growth factor (EGF), a known inhibitor of
lactogenic differentiation in HC11 cells, blocks lactogenesis,
the HC11 cells stimulated with lactogenic hormone in the
presence of EGF were profiled. This data revealed EGF
regulation of a specific subset of genes including important
cell cycle regulators. The studies confirm the value of
expression profiling in defining gene transcription associated
with differentiation of mammary epithelial cells.
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Introduction
The mammary gland undergoes periodic cycles of growth,
differentiation and regression throughout adult life. Normal
mammary gland development is dependent on signals from
growth factors, mammotrophic hormones, and tissue
stroma, and the dysregulation of these process can lead to
mammary epithelial hyperplasia and tumorigenesis. The
HC11 cell line was derived from the COMMA1D cells,
which originated from the mammary gland tissue of a
pregnant BALB/c mouse (Danielson et al. 1984). HC11
cells are an excellent model system for studying differen-
tiation states of mammary epithelial cells. These cells retain
important characteristics of normal mammary epithelial
cells including the synthesis of the milk protein ß-casein in
vitro upon treatment with lactogenic hormones (Ball et al.
1988). HC11 cells also exhibit normal ductal morphogen-
esis when injected into the cleared fat pad of syngeneic
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mammary epithelial cells is the activation of the epidermal
growth factor (EGF) receptor during the growth phase. In
HC11 cells, activation of the EGF receptor promotes
growth and is required for the establishment of competence
to respond to the lactogenic hormones. Following EGF
removal, HC11 cells differentiate in vitro in response to the
synergistic actions of insulin, glucocorticoids, and prolactin
(DIP) (Ball et al. 1988; Taverna et al. 1991). However, the
inclusion of EGF in the lactogenic hormone mix blocks
differentiation (Hynes et al. 1990; Marte et al. 1995b;
Merlo et al. 1996; Peterson and Haldosen 1998). The
regulatory mechanisms for signal transduction pathways
controlling development of the mammary gland epithelium
and the molecular switch from proliferation to differentia-
tion have been studied in recent years. Prolactin stimulation
results in the phosphorylation and nuclear translocation of
Stat5 and Stat5 binds to the β-casein promotor initiating its
transcription (Ali 1998; Gouilleux et al. 1994; Han et al.
1997; Marte et al. 1995b; Stocklin et al. 1996). The
activation of β-casein transcription is enhanced by the
glucocorticoid receptor (Nagaiah et al. 1981; Stocklin et al.
1996). While these studies addressed the requirements for
milk protein transcription other changes contributing to
lactogenic differentiation are less well understood.
HC11 mammary epithelial cell differentiation was ex-
amined using two-dimensional gels and proteomic tech-
niques to decipher differences between the protein patterns
of growing versus differentiating cells (Desrivieres et al.
2003). This study identified approximately sixty proteins
whose expression levels changed following four days of
differentiation. These proteins include cytoskeletal compo-
nents, molecular chaperones and regulators of protein
folding and stability, calcium-binding proteins, and compo-
nents of RNA-processing pathways. More recently a
proteomic study of nuclear protein changes in HC11 cells
undergoing differentiation revealed differential expression
of several transcription factors that have the potential to
regulate mammary differentiation or development as well as
proteasome subunits, hnRNPs and HSPs (Desrivieres et al.
2007). The profile of induced proteins provided insights
into the mechanistic differentiation of HC11 mammary
epithelial cells and the regulation of this process. Gene
expression profiling using DNA microarrays allows the
concurrent analysis of thousands of genes and has been
applied to provide insight into the regulatory and functional
pathways involved in mouse mammary gland development
(Master et al. 2002; Clarkson and Watson 2003; Gass et al.
2003; Rudolph et al. 2003). These studies measure
transcription in all cells in the mammary gland including
stroma and immune cells. In the study reported here,
oligonucleotide microarrays containing approximately
20,000 genes were used to examine the gene expression
patterns during lactogenic differentiation of the HC11
mammary epithelial cell line. The study confirms that HC11
cells undergoing lactogenic differentiation in culture recapit-
ulate the process in the mammary gland. In addition, the
results identify potential signaling pathways not previously
associated with mammary differentiation. Among the newly
identified molecules contributing to lactogenic differention
the rapid elevation of CTGF/CCN2 and osteopontin are
highly significant as these proteins are known to play a role in
tissue remodeling and the pathology of breast cancer.
Materials and methods
Cell preparation HC11 mouse mammary epithelial cells
were cultured in RPMI 1640 medium containing 10% fetal
calf serum, 5µg/ml Insulin, 10 mM Hepes and 10 ng/ml
epidermal growth factor (EGF) (Cerrito et al. 2004). For
differentiation the cells were maintained in T75 flasks for
4 days after reaching confluence, then exposed to media
without EGF for 24 h. The cells were then incubated in DIP
differentiation media, serum-containing RPMI with dexa-
methasone (10
−6M), insulin (5µg/ml) and prolactin (5µg/ml)
for 72 h and undifferentiated HC11 cells were maintained in
growth media and these served as a control. In another set of
experiments, control cells were incubated in DIP differentia-
tion media for 72 h, while experimental cells were incubated
inDIPdifferentiationmediaexceptthatEGFwaspresent.The
cells were scraped from the flasks for RNA extraction.
RNA preparation RNA was extracted using Trizol reagent
(Invitrogen) and RNeasy maxi kit (Qiagen). RNA samples
were concentrated to greater than 1 mg/ml by centrifugation
on a MicroCon 100 filter unit at 500 g. The concentration
and 260/280 OD ratio of the RNA was determined by
spectrophotometry and RNA was stored at −80°C. Alterna-
tively, the RNA was purified to recover mRNA using
Oligtex mRNA kit.
Labeling, hybridization and analysis Mouse (Develop-
ment) Oligo Microarrays were purchased from Agilent
Technologies. The content on this microarray was derived
from the National Institute on Aging/National Institute of
Health cDNA mouse clone set that includes genes from
sequences of stem cells and very early-stage embryo cDNA
libraries. It contains 20,371 60-mer oligonucleotides repre-
senting over 20,000 known mouse genes. Detailed process
for labeling and hybridization were according to manufac-
turer’s manual. Briefly, fluorescent cRNA was synthesized
using low RNA input fluorescent linear amplification kit
from Agilent Technologies. 500 ng of total RNA was used
in each experiment. In the differentiation experiments, five
slides were used (repetitions N=5), DIP treated RNA was
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with cyanine 3-CTP. In differentiation blocking experi-
ments, six slides were used (N=6), EGF treated DIP RNA
was labeled with cyanine 5-CTP, while DIP treated RNA
was labeled with cyanine 3-CTP. Amplified cRNA was
purified using Qiagen’sR N e a s ym i n is p i nc o l u m n s .H y b r i d -
ization was carried out using In situ Hybridization Kit Plus
from Agilent Technologies, 750 ng of cyanine 3 and cyanine
5 labeled cRNA was used in each hybridization. Hybridiza-
tion continued at 60°C for over 17 h. Post hybridization
washes includes 6 X SSC, 0.005% Triton X-102 (10 min),
and 0.1 X SSC, 0.005% Triton X-102 (5 min) followed by
drying with nitrogen gas and immediate scanning. Scanning
was performed by GenePix 4000A scanner (Axon instru-
ments, Inc., Foster city, CA) with Axon GenePix image
acquisition and analysis software. Analysis of gene expres-
sion was performed using BRB-Array Tools Version 3 which
was developed by Biometrics Research Branch, NCI (http://
linus.nci.nih.gov/BRB-ArrayTools.html).
In addition, a smaller study using oligonucleotides arrays
representing 3800 genes (Atlas Glass Mouse 3.8 Micro-
arrays from Clontech) (N=4) was performed. Fluorescent
labeling of RNAs was performed by using an Atlas Glass
fluorescent labeling kit (Clontech Laboratories) according
to manufacturer’s protocol. Synthesized first-strand cDNAs
from RNA of HC11 cells with and without differentiation
were labeled with fluorescent dyes, Cy3 and Cy5 (Amer-
sham Pharmacia Biotech), respectively. The reciprocal
labeling was used during the experiment, i.e. differentiation
group was labeled with Cy3 two times, and Cy5 two times;
and the control group was labeled with Cy5 two times, and
Cy3 two times. The quality of the labeling and the amount of
each probe used were determined by absorbance measure-
ment for Cy3 and Cy5 probes in a Beckman DU-600 scanner.
Hybridization of the microarrays was carried out in a hy-
bridization solution for 16 h at 50°C. The slides were washed
3 times. The microarray slides were scanned and analyzed by
using a GenePix 4000B scanner in both Cy3 and Cy5
channels. The control value was obtained from four experi-
ments and used to determine the differentiation induced gene
up- or down-regulations. The average of the Cy3 and Cy5
signals from nine house-keeping genes were used to obtain a
ratio value for normalization of the individual signals. Much
of the information obtained from the differentiation experi-
ments analyzed on the smaller oligonucleotide based arrays,
Clontech3.8Karrays,werecontainedwithinthelarger20280
gene set data. However, Supplemental file 3 contains the list
of genes detected as differentially expressed during lacto-
genic differentiation of HC11 cells on 3.8 K arrays.
Statistical Analysis of Microarray Normalization and analy-
sis of the gene expression profiles were performed as
follows: the spot was excluded if red and green intensity
was below 30. Each array was normalized (centered) using
the median over entire array. Intensity ratios (and inverse
ratios) greater than 64 were truncated. Genes were excluded
under any of the following conditions: less than 20 % of
expression data had at least a 1.5 -fold change in either
direction from gene’s median value or if the percentage of
data that was missing or filtered out exceeded 50%.
In DIP versus control experiments, there are 10813
genes that passed filtering criteria in total of 20280 genes.
And the first 2479 genes are significant at the nominal 0.05
level of the paired T-test. In EGF plus DIP versus DIP
experiments, there are 1386 genes passed filtering criteria
in total of 20280 genes. And the first 1129 genes are
significant at the nominal 0.05 level of the paired T-test.
Generation of probes In order to generate DNA hybridiza-
tion probes, the accession number of interested gene was
used to obtain the mRNA sequence and primers were
designed for RT-PCR to produce a DNA fragment several
hundred basepairs in length. RT-PCR products were
inserted into a pCR2.1 TA cloning vector (Invitrogen) and
the identities of candidate clones were confirmed by DNA
sequence. Double strand DNA plasmid inserts were isolated
by restriction endonuclease digestion of the pCR2.1
plasmid and the released DNA fragment was gel purified
for use as a hybridization probe. The fragments cloned and
amplified include: PIP, position 77 to 477 in cDNA
(accession number NM_008843); KLF9 (Bteb1), position
932 to 1262 in cDNA (accession number NM_010638);
SGK position 92 to 592 in cDNA(accession number NM_
011361); AP3 position 92 to 592 in cDNA (accession num-
ber NM_009681); Spi-C position 362 to 862 in cDNA
(accession number NM_011461). The probes and primers
for CTGF/CCN2, β-casein, and actin have been described
(Wang et al. 2008).
Northern blot and Realtime PCR For northern blot experi-
ments, HC11 cells were treated identically to the methods
in the microarray experiment, and then exposed to DIP
differentiation media for 0, 12, 24, 48, 72 and 96 h,
respectively. RNA was extracted for northern blot by using
Trizol reagent. In some experiments, the same RNA
preparations used in Agilent Microarrays were utilized.
RNA from mouse mammary gland at distinct stages of
pregnancy and lactation were prepared as described (Wang
et al. 2008). Northern blotting was performed as described
(Cerrito et al. 2004; Galbaugh et al. 2006). Beta-actin probe
was hybridized to the same membrane and scanned on
Packard beta scanner for normalization purposes. Realtime
PCR was performed using SYBR green PCR kits and a
7500 RealTime PCR instrument (Applied Biosystems).
Primers include: actin forward 5’ TTACTGCTCTGGCTCC
TAGCA, reverse 5’ GACTCATCGTACTCCTGCTTGC;
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mouse CTGF 3’UTR, forward 5’ACAGTTGTTCATTAG
CGCAC and reverse: 5’CTATGGTGTTTGGAGTTTGA.
Expression vector construction The open reading frame of
identified genes was tagged with the myc epitope tag by
PCR and inserted into pCR3.1 vector (Invitrogen) as
described (Wang et al. 2008). The clones were verified by
DNA sequencing prior to use in expression studies.
Results
Lactogenic differentiation-induced gene expression in
HC11 cells To follow the global changes in gene transcrip-
tion in HC11 mouse mammary epithelial cells undergoing
lactogenic differentiation, we employed an oligonucleotide
based microarray technique. The experiments were per-
formed with RNA extracted from HC11 cells maintained in
either growth media or HC11 cells exposed to lactogenic
differentiation media containing dexamethasone, insulin
and prolactin (DIP). HC11 cells undergoing lactogenic
differentiation have a unique phenotypic appearance as
clusters of enlarged cells in dome-like structures, referred to
as mammospheres, appear in the culture (Fig. 1c). Total
RNAwas purified from the cells and fluorescent cRNAwas
synthesized. In the differentiation experiments (N=5), RNA
from DIP treated cells was labeled with cyanine 5-CTP, and
RNA from the control cells was labeled with cyanine 3-
CTP. Differences in gene expression were detected by
hybridization of labeled RNA to slide-based oligonucleo-
tide microarrays. The NIA mouse development oligonucle-
otide microarrays containing 20280 genes (produced by
Fig. 1 Northern blotting of genes exhibiting elevated expression in
HC11 cells undergoing lactogenic differentiation. a. HC11 mouse
mammary epithelial cells were cultured in complete medium with
EGF for 4 days post confluence followed by incubation in the media
without EGF for 24 h. The cells were then stimulated with
differentiation media containing dexamethasone (10
−6M), insulin
(5µg/ml) and prolactin (5µg/ml) for 0, 12, 24, 48, and 72 h. RNA
was extracted and used for northern blots. The probes are described in
Materials and Methods. The fold changes of gene expression of each
probe normalized to β-actin is shown. b. Northern blotting of genes
exhibiting elevated expression in HC11 cells hybridized to RNA from
mouse mammary glands. The probes used in part Awere hybridized to
northern blots of RNA extracted form mouse mammary glands at
various stages of pregnancy and lactation. The RNAs are from
pregnancy days 10, 12 and 16; lactation days 1 and 3; involution days
1 and 7; and NP represents RNA from non-pregnant mammary glands
of adult female mice. The blots were hybridized to β-actin as a
loading control. C. HC11 cells undergoing lactogenic differentiation.
Control=untreated cells, DIP=cells exposed to DIP for 5 days. Top
panel: cells at magnification 200X; bottom panel: cells at magnifica-
tion of 500X
46 W. Wang et al.mean of log ratio GB acc Description
17.067 NM_010217.1 connective tissue growth factor
13.447 NM_138314.1 protein expressed in non-metastatic cells 7
11.15 XM_150141.2 LOC234574
9.52 NM_009263.1 secreted phosphoprotein 1
7.69 BC009155.1 microsomal glutathione S-transferase 1
7.64 NM_022032.1 p53 apoptosis effector related to Pmp22
6.99 NM_011326.1 sodium channel, nonvoltage-gated 1 gamma
6.44 NM_009681.1 adaptor-related protein complex AP-3, sigma 1 subunit
6.34 NM_029083.1 RIKEN cDNA 5830413E08 gene
5.92 BC036990.1 metallothionein 1
5.85 XM_123496.1 Tcfcp2-related transcriptional repressor 1
5.78 NM_007621.1 carbonyl reductase 2
5.77 NM_138578.1 Bcl2-like
5.76 NM_012519.1 calcium/calmodulin-dependent protein kinase II, delta
5.72 NM_009976.1 cystatin C
5.42 NM_010286.1 glucocorticoid-induced leucine zipper
5.15 NM_009128.1 stearoyl-Coenzyme A desaturase 2
5.14 NM_025610.1 RIKEN cDNA 2410004D18 gene
5.13 NM_011361.1 serum/glucocorticoid regulated kinase
4.88 AK009928.1 RIKEN cDNA 2310051E17 gene
4.82 NM_011313.1 S100 calcium binding protein A6 (calcyclin)
4.79 AF434663.1 immunoglobulin superfamily, member 4
4.75 NM_010730.1 annexin A1
4.60 NM_026217.1 autophagy 12-like (S. cerevisiae)
4.60 NM_025436.1 sterol-C4-methyl oxidase-like
4.52 NM_010884.1 N-myc downstream regulated 1
4.48 XM_177182.1 expressed sequence C85344
4.44 NM_011400.1 solute carrier family 2 (facilitated glucose transporter)
4.41 NM_011803.1 core promoter element binding protein
4.41 NM_010907.1 nuclear factor of kappa light chain gene enhancer
4.34 NM_013470.1 annexin A3
4.33 NM_145942.1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
4.21 AL080093.1 expressed sequence AU067636
4.16 XM_132485.1 RAS-related C3 botulinum substrate 1
4.11 NM_010762.1 myelin and lymphocyte protein, T-cell differentiation
4.10 NM_009983.2 cathepsin D
4.08 AF378830.1 prostaglandin-endoperoxide synthase 2
4.05 NM_145977.1 RIKEN cDNA 2210413P12 gene
4.01 NM_146120.1 gelsolin
3.98 BC020081.1 RIKEN cDNA 2310016C08 gene
3.95 BC019207.1 low density lipoprotein receptor
3.95 NM_053623.1 expressed sequence AU018108
3.93 NM_019971.1 platelet-derived growth factor, C polypeptide
3.92 NM_013492.1 clusterin
3.89 NM_008084.1 glyceraldehyde-3-phosphate dehydrogenase
3.87 BC038392.1 ATPase, H+transporting, lysosomal 70kD, V1
3.85 NM_033079.1 DNA segment, Chr 6, Miriam Meisler 5, expressed
3.84 BC037116.1 adducin 3 (gamma)
Table 1 Elevation of gene
expression following stimulation
of HC11 cells with DIP
Regulation of gene expression
in HC11 cells undergoing lacto-
genic differentiation. To deter-
mine the effect of lactogenic
differentiation on gene tran-
scription in HC11 cells oligonu-
cleotide microarrays
representing 20280 genes (NIA
20 k arrays from Agilent Tech-
nologies) were hybridized with
RNA from DIP treated HC11
cells. The RNAwas labeled with
cyanine 5-CTP and control
RNA was labeled with cyanine
3-CTP. Fluorescent cRNA was
synthesized and hybridized in
the differentiation experiments
(N=5) as described in Materials
and Methods. Analysis of gene
expression was performed using
BRB-Array Tools Version 3. In
The HC11-DIP versus HC11-
control RNA experiments, there
are 10813 genes that passed
filtering criteria in total of 20280
genes. The first 2479 genes were
significant at the nominal 0.05
level of the paired T-test, and
998 genes met the 2-fold change
criteria. Table 1 shows the first
50 genes with elevated expres-
sion in cells undergoing lacto-
genic differentiation
Global expression profiling reveals regulation of CTGF/CCN2 47Agilent Technologies) were employed for the study. Hy-
bridization reactions were analyzed using an Axon micro-
array reader. Normalization and statistical analysis and the
analysis of gene expression using BRB-Array Tools
Version 3 was performed as described in the Materials
and Methods Section.
In the experiments comparing HC11 cells induced to
differentiate with HC11 control cells (DIP versus control),
there were 10813 genes that passed filtering criteria from a
total of 20280 genes on the NIA microarrays. The changes
in expression of 998 genes met the 2-fold change criteria.
Table 1 shows the partial list of genes exhibiting increased
expression during lactogenic differentiation of HC11 cells
and Supplemental File 1 contains the information on the
998 genes that met the 2-fold change at the p value 0.05. In
the case studies carried out using the NIA 20280 gene
arrays fewer genes exhibited a significant reduction in
expression than an increase in expression during the 72 h
differentiation period. Table 2 contains a partial list from
the 20 genes exhibiting a minimum two-fold decrease.
Elevated expression of hormone-regulated genes, genes
associated with cell cycle control or cell survival and tissue
reorganization during lactogenic differentiation of HC11
cells The genes induced during lactogenesis included
transcriptional regulatory factors, proteins involved in
growth control and survival, tissue re-organization and
proteins important for milk production. Several previous
studies performed on mouse mammary gland tissue
reported alterations in the expression of genes that impact
numerous pathways (Clarkson and Watson 2003) (Gass et
al. 2003) (Anderson et al. 2007; Rudolph et al. 2007) (Stein
et al. 2007). The majority of the studies examined changes
in gene expression using RNA that was derived from the
multiple cell types making up the mammary glands. In the
present study the expression changes are restricted to genes
expressed in epithelial cells. Therefore, while our findings
confirm many of the findings of previous studies, all the
changes reported are restricted to epithelial cells. Hence,
some of the differences between HC11 cells and mammary
tissue may be attributed to the lack of stromal or immune
cell components in our analysis. Some examples of the
functional divisions represented among DIP-regulated
genes are included in Table 3. Many of the changes relate
to milk protein production, but transcription factors and
regulators, genes for growth control and tissue reorganiza-
tion are well represented as are genes regulated by gluco-
corticoids and prolactin.
Genes exhibiting significant changes in expression as a
result of DIP-stimulation of HC11 cells were selected for
analysis by northern blot to confirm the results obtained by
microarray (Fig. 1a). The use of northern blotting for this
aspect of the study allowed confirmation of the size of the
mRNA in addition to the amount of RNA. Northern blots of
HC11 cell RNA from cells stimulated with DIP for 0 to
72 h were hybridized with specific probes as well as a
probe for actin. Following hybridization the results were
quantified using a β-scanner and the fold changes in
expression were obtained by normalization to β-actin
expression. The normalized data revealed a positive
correlation between the fold changes obtained in the
microarray and the northern blot (Fig. 1). The expression
of target genes was also analyzed by real-time PCR and the
results support those obtained by northern blot. (data not
shown). These data clearly demonstrated the significant
increase in CTGF/CCN2 and SPP1/osteopontin gene
expression following lactogenic stimulation of HC11 cells.
To ascertain if the genes detected in the array analysis
were similarly regulated in the mouse mammary gland in
vivo RNA from pregnant and lactating mouse mammary
glands was analyzed. Northern blots containing RNA from
non pregnant, pregnant, lactating and involuting mouse
mammary gland tissue were hybridized to probes encoding
genes differentially expressed in DIP-stimulated HC11
cells. The results in Fig. 1b indicate that a number of the
genes exhibit modest increases in expression during
pregnancy and lactation. A number of the genes tested in
this way, excluding β-casein, were also expressed in non-
pregnant mammary glands but little or no expression of the
specifc RNAs was detected during postlactation involution
of the mammary gland.
Table 2 Genes exhibiting decreased expression following stimulation
of HC11 Cells with DIP
Mean of
log ratio
GB acc Description
0.66 NM_007671.1 cyclin-dependent kinase inhibitor
2C (p18)
0.59 NM_009335 transcription factor AP-2, gamma
0.56 NM_007631.1 cyclin D1
0.56 Mm.11987 ESTs, Moderately similar to
POL2_MOUSE
0.53 Mm.173695 ESTs, Moderately similar to
cofactor forSp1
0.47 AF316985.1 toll-like receptor 1
0.44 NM_021355.1 fibromodulin
0.44 M_008086.1 growth arrest specific 1
0.37 C012724.1 insulin-like growth factor binding
protein 2
Decreased gene expression in HC11 cells undergoing lactogenic
differentiation. RNA from HC11 cells undergoing lactogenic differ-
entiation and HC11 control cells was analyzed for changes in gene
transcription using oligonucleotide microarrays as described in the
legend of Table 1. The results in Table 2 show the genes with
significantly decreased expression in HC11 cells undergoing lacto-
genic differentiation
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chondrocytes and renal epithelia. Hence, further studies
explored the steroid regulation of CTGF/CCN2 expression
in HC11 cells. While treatment of HC11 cells with
Table 3 Functional division of lactogenic differentiation-regulated
genes
A. Up-Regulated genes
Prolactin Regulated
NM_008843 prolactin induced protein
NM_009972 casein beta
Dexamethasone Regulated
NM_011361 serum/glucocorticoid regulated kinase
NM_010286 glucocorticoid-induced leucine zipper
NM_010217 CTGF/CCN2
NM_010730.1 annexin A1
Milk production: including carbohydrate and lipid metabolism
NM_019739.1 Fox O1
AF378830.1 prostaglandin-endoperoxide synthase 2
NM_013467 alcohol dehydrogenase family 1, subfamily
NM_007607 carbonic anhydrase 4
NM_007621.1 carbonyl reductase 2
NM_009128.1 stearoyl-Coenzyme A desaturase 2
NM_025436.1 sterol-C4-methyl oxidase-like
NM_145942.1 3-hydroxy-3-methylglutaryl-Coenzyme A
synthase 1
NM_008084.1 glyceraldehyde-3-phosphate dehydrogenase
BC038392.1 ATPase, H+ transporting, lysosomal
BC019207.1 low density lipoprotein receptor
NM_019703.1 phosphofructokinase, platelet
NM_134469.1 farnesyl diphosphate synthetase
NM_013820.1 hexokinase 2
NM_010687.1 like-glycosyltransferase
NM_009270.1 squalene epoxidase
U12330.1 sterol regulatory element binding factor
NM_028803.1 glucan (1,4-alpha-), branching enzyme 1
NM_007408.1 adipose differentiation related protein
XM_131456.2 solute carrier family 31, member 1
NM_011400.1 solute carrier family 2glucose transporter)
NM_008489 lipopolysaccharide binding protein
Apoptosis
NM_022032.1 Perp, p53 apoptosis effector
NM_138578.1 Bcl2-like
NM_026217.1 autophagy 12-like
U05989.1 Par-4
NM_019745.1 programmed cell death 10
NM_013492.1 clusterin
Cytoskeleton, extracellular matrix, membrane structure
NM_146120.1 gelsolin
NM_009071.1 Rho-associated coiled-coil kinase 1
XM_132485.1 RAS-related C3 botulinum substrate
BC037116.1 adducin 3 (gamma)
NM_013470.1 annexin A3
NM_011313.1 S100 calcium binding protein A6 (calcyclin)
BC013248.1 kinesin family member 5B
XM_130768.1 laminin, alpha 5
Table 3 (continued)
A. Up-Regulated genes
NM_130448.1 protocadherin 18
NM_007404.1 ADAM-9 (meltrin gamma)
D67076.1 ADAMTS-1
NM_009263.1 secreted phosphoprotein/ostepontin
NM_010217 CTGF/CCN2
NM_010728.1 lysyl oxidase
NM_009983.2 cathepsin D
NM_144554.1 claudin 4
BC038280.1 caveolin, caveolae protein, 22 kDa
NM_016900. caveolin 2
Transcription Factors and regulators
NM_011461 Spi-C ETS transcription factor
XM_123496.1 Tcfcp2-related transcriptional repressor 1
NM_011803.1 CPEBP
NM_057211.1 Kruppel-like factor 9
NM_019739.1 Fox O1
NM_010907.1 inhibitor of NFkB
Growth Control and Signaling
NM_007669.1 cdk inhibitor 1A (P21)
NM_007635.1 cyclin G2
NM_008960.1 phosphatase and tensin homolog
NM_010515.1 insulin-like growth factor 2 receptor
NM_021099.2 kit oncogene
NM_007918.1 eukaryotic translation initiation factor 4E
binding protein 1
NM_009721 ATPase, Na+/K+transporting, beta 1 poly
BC009155.1 microsomal glutathione Stransferase 1
NM_010884.1 N-myc downstream regulated 1
NM_019971.1 PDGF, C polypeptide
NM_011057 PDGF, B polypeptide
NM_012671.1 transforming growth factor alpha
NM_011338 small inducible cytokine A9
NM_011944 MAPKK
NM_012519.1 calcium/calmodulin-dependent protein
kinase II, delta
AF378830.1 prostaglandin-endoperoxide synthase 2
BC038069.1 IGFBP5
BC002092.1 v-maf oncogene family, protein G
The functional division of genes transcriptionally regulated in HC11
cells undergoing lactogenic differentiation. The list of genes that
exhibit elevated expression in HC11 cells undergoing lactogenic
differentiation are categorized in functional divisions. The list does not
include all genes with 2-fold or greater increase and some genes are
listed in more than one category
Global expression profiling reveals regulation of CTGF/CCN2 49dexamethasone induced expression of CTGF, neither
estrogen nor progesterone produced the same result and
CTGF/CCN2 expression was not dependent on TGFβ in
these cells (Wang et al. 2008). The realtime PCR results in
Fig. 2 demonstrate that the glucocorticoid receptor antag-
onist RU486 efficiently blocked CTGF/CCN2 expression
in response to dexamethasone confirming the function of
the steroid hormone in the HC11 cells. Our additional
studies demonstrated that CTGF/CCN2 is required for
HC11 lactogenic differentiation and that ectopic expression
of CTGF/CCN2 enhances differentiation in HC11 cells as
well as in primary mouse mammary epithelial cell cultures
(Wang et al. 2008).
Regulation of gene expression by EGF during lactogenic
differentiation in HC11 cells EGF, or other potent mito-
gens, are required for the proliferation and development of
“competency” of HC11 cells to differentiate (Marte et al.
1995a; Merlo et al. 1994; Taverna et al. 1991). However,
the inclusion of EGF, other mitogenic growth factors or
expression of transforming oncogenes in HC11 cells blocks
lactogenic differentiation (Cerrito et al. 2004; Hynes et al.
1990; Marte et al. 1995a; Merlo et al. 1996; Peterson and
Haldosen 1998). To examine the effect of EGF on the DIP-
induced expression pattern of the HC11 cells another
microarray experiment was performed. For this study
RNA was extracted from HC11 cells induced to differen-
tiate with DIP and from HC11 cells stimulated with DIP
containing 10 ng/ml EGF. Total RNA was purified and
fluorescent cRNA was synthesized as described above.
RNA from DIP plus EGF treated cells was labeled with
cyanine 5-CTP, and RNA from DIP-treated cells was
labeled with cyanine 3-CTP. Hybridization was carried out
and the results were analyzed as described above. The
analysis of gene expression revealed that in EGF plus DIP
versus DIP experiments 1129 genes are significant at the
nominal 0.05 level of the paired T-test, and 128 genes met
the 2-fold change criteria. Table 4 shows the partial list of
genes for which expression was regulated by EGF in the
presence of DIP. The remainder of the data is contained in
Supplemental file 2. Many of the genes expressed at higher
level in the EGF plus DIP-stimulated cells are known
targets of EGF signal transduction pathways or are
associated with malignant growth, for example cyclin D1
and osteopontin.
Confirmation of the array results for a number of genes
was performed by northern blotting. RNA from undiffer-
entiated HC11 cells or cells stimulated with either DIP or
DIP plus EGF was hybridized to probes for several
differentially expressed genes. The results are shown in
Fig. 3. The genes that are transcriptionally activated by DIP
were generally unaffected by the inclusion of EGF in the
differentiation media. However, it was clear that the
expression of cyclin D1 decreased during differentiation
but it increased with inclusion of EGF in the differentiation
media. This finding reflects the increase in the level of
cyclin D1 in the microarray analysis.
Discussion
Several microarray studies have examined transcriptional
control in mouse mammary epithelial cells undergoing
lactogenic differentiation (Kelly et al. 2002; Clarkson and
Fig. 2 CTGF/CCN2 expression is regulated by dexamethasone in
HC11 cells. HC11 mammary epithelial cells were grown to confluence
and stimulated with dexamethasone (DEX)(1μM) in serum-containing
media in the presence of insulin. RU486 at varying concentrations or
vehicle (ethanol) was added to cells alone or in combination with
dexamethasone. RNAwas isolated and levels of CTGF and actin RNA
were determined by realtime PCR. The results indicate the induction
of CTGF/CCN2 normalized to actin. *These Dex+Ru486 values
represent statistically significant difference (p-value .001) from the
Dex alone condition
50 W. Wang et al.Watson 2003; Rudolph et al. 2003; Rudolph et al. 2007). In
addition, proteomics analyses have been used to examine
changes at the level of the protein expression in differen-
tiating HC11 cells (Desrivieres et al. 2003) (Desrivieres et
al. 2007). Our study analyzed mammary epithelial cell
lactogenic differentiation and developed a global expres-
sion profile of HC11 cells undergoing differentiation using
oligonucleotide microarrays. In addition, the changes in
gene expression that occur as a result of mitogenic
stimulation of HC11 cells undergoing lactogenic differen-
tiation were analyzed. To qualify the accuracy of the
microarray data both northern blot and real-time PCR
techniques were used, and results showed very good
correspondence. While numerous genes were regulated
during differentiation (Table 1), the analysis of expression
in different functional pathways (Table 3) revealed some
changes not previously observed either by proteomic
Table 4 Partial list of genes transcriptionally regulated by EGF
(DIP+EGF) versus DIP
Expression elevated in DIP+EGF
Mean log
ratio
GB acc Description
2.63 NM_009263.1 secreted phosphoprotein 1
2.54 NM_016980.1 ribosomal protein L5
2.52 AF378830.1 prostaglandin-endoperoxide synthase 2
2.46 NM_008972.1 prothymosin alpha
2.35 NM_009121.1 spermidine/spermine N1-acetyl
transferase
2.33 NM_019682.1 dynein, cytoplasmic, light chain 1
2.32 BC006739.1 catenin beta
2.31 NM_133777.2 ubiquitin-conjugating enzyme E2S
2.30 NM_023372.1 ribosomal protein L38 (Rpl38),
transcript variant 2
2.29 NM_007631.1 cyclin D1
2.28 BC010581.1 stathmin 1
2.28 XM_134967.2 eukaryotic translation elongation
factor 1 alpha 1
2.27 NM_031165.1 heat shock protein 8
2.27 NM_022891.1 ribosomal protein L23
2.26 NM_008305.1 perlecan (heparan sulfate
proteoglycan 2)
2.26 NM_025592.2 ribosomal protein L35
2.26 NM_009608.1 actin, alpha, cardiac
2.26 BC034257.1 epithelial membrane protein 1
2.25 NM_019703.1 phosphofructokinase, platelet
2.25 XM_178595.1 chromobox homolog 3
(Drosophila HP1 gamma)
2.23 NM_133834.1 expressed sequence AA407306,
2.23 NM_009255.1 serine (or cysteine) proteinase inhibitor,
clade E,
2.22 BC010726.1 phospholipase A2, group VII
(platelet-activating factor)
2.22 NM_013261.1 peroxisome proliferative activated
receptor, gamma,
2.22 XM_129211.2 phosphoserine aminotransferase
2.21 NM_010480.1 heat shock protein, 1
2.21 NM_025919.1 ribosomal protein L11 (Rpl11)
2.20 XM_128846.2 similar to 60 S RIBOSOMAL
PROTEIN L17 (L23)
2.20 BC012508.1 SET translocation
2.20 NM_145142.1 HNK-1 sulfotransferase
2.19 NM_009076.1 hypothetical pseudogene ribosomal
protein L12
2.19 NM_007961.1 ets variant gene 6 (TEL oncogene)
2.17 AK021352.1 RIKEN cDNA D730048J04 gene
(day10 lact mamm gland)
2.17 NM_028044.1 calponin 3, acidic
2.16 BC003308.1 casein kinase 1, delta
2.15 NM_011400.1 solute carrier family 2
(facilitated glucose transporter),
Table 4 (continued)
Expression elevated in DIP+EGF
Mean log
ratio
GB acc Description
2.14 NM_008774.1 poly A binding protein, cytoplasmic 1
2.14 XM_135387.1 similar to 40 S RIBOSOMAL
PROTEIN S19
2.14 BC002046.1 ephrin A1
2.13 NM_011218.1 protein tyrosine phosphatase,
receptor type, Sigma
2.13 XM_126364.1 similar to ATP synthase,
H+transporting, mitochondrial
Expression lower in presence of EGF
0.56 NM_002747 MAPK4
0.59 L25602.1 BMP-2
0.59 mannose-6-phosphate
receptor transporter
0.59 NM_011224.1 muscle glycogen phosphorylase
0.59 NM_011500.1 striatin
0.58 NM_021454.1 cdc42 effector protein
0.57 NM_010086.1 ADAM24
0.56 NM_008372.2 interleukin 7 receptor
0.56 U44955.1 connexin 3
0.55 NM_020496.1 T-box 20
0.50 BC033410.1 eukaryotic translation initiation
factor 4E
Genes exhibiting elevated or decreased gene expression in HC11 cells
undergoing lactogenic differentiation in the presence of EGF
compared to HC11 lactogenic controls. RNA from HC11 cells
undergoing lactogenic differentiation in the presence or absence of
10 ng/ml EGF was analyzed for changes in gene transcription using
oligonucleotide microarrays as described in Materials and Methods.
The results include genes exhibiting a greater than two-fold increase
or significant decrease in the presence of EGF
Global expression profiling reveals regulation of CTGF/CCN2 51studies of HC11 cells or by the analysis of the lactational
switch in the mouse mammary gland.
A number of proteins that regulate aspects of the ex-
tracellular matrix were expressed in differentiating HC11
cells. Two members of the small integrin binding protein
family, connective tissue growth factor (CTGF/CCN2) and
secreted phosphoprotein (SPP1/osteopontin) were transcrip-
tionally activated during lactational differentiation of HC11
cells suggesting that these proteins may play a role in
extracellular matrix accumulation necessary for competence
to undergo differentiation. CTGF/CCN2, a CCN protein, is
a cysteine-rich protein that can modulate numerous cellular
responses including proliferation, chemotaxis, adhesion,
migration, and extracellular matrix production (Perbal
2004; Brigstock 2002; Brigstock 2003; Leask and Abraham
2006). CTGF/CCN2 promotes endothelial cell growth,
migration, adhesion, and survival in vitro, and CTGF action
in angiogenesis is mediated at least partly through
interactions with integrins (Ivkovic et al. 2003; Gao and
Brigstock 2004; Gao and Brigstock 2006). Appropriate
integrin signaling is required for lactogenic differentiation
in vivo (Li et al. 2005; Naylor et al. 2005). The expression
of integrins is regulated during lactogenesis in mouse
mammary gland (Kelly et al. 2002; Clarkson and Watson
2003; Rudolph et al. 2003; Rudolph et al. 2007). Profibrotic
activity of CTGF/CCN2 is related to high levels in many
fibrotic lesions, and CTGF/CCN2 is induced by and acts as
a co-factor for transforming growth factor β in the
induction of fibrogenesis (Perbal 2004). In our study,
CTGF/CCN2 is highly up-regulated in differentiated
HC11 cells, suggesting that it might play an important role
in matrix signals required for differentiation. However,
expression of CTGF/CCN2 in HC11 cells does not require
TGFβ, its expression is induced by dexamethasone (Wang
et al. 2008). Moreover, ectopic expression of CTGF/CCN2
enhances HC11 lactogenic differentiation and depletion of
CTGF inhibits differentiation (Wang et al. 2008).
Secreted phosphoprotein1(SPP1)/ osteopontin is a se-
creted glycoprotein that is rich in aspartate and sialic acid
residues (Craig et al. 1988) and contains functional
domains for calcium-binding, phosphorylation, glycosyla-
tion, and extra-cellular matrix adhesion (Kazanecki et al.
2007). Osteopontin is associated with cartiledge and bone
but has multiple molecular functions that mediate cell
adhesion, chemotaxis, macrophage-directed interleukin-10
suppression, stress-dependent angiogenesis, prevention of
apoptosis, and anchorage-independent growth of tumor
cells (Mi et al. 2004). A substantial body of data has
recently linked osteopontin with the regulation of metastatic
spread by tumor cells (Hayashi et al. 2007). A number of
genes that are transcriptionally activated in HC11 cells
undergoing lactogenic differentiation are also regulated
during skeletogenesis. A recent study identified a number
Fig. 3 Northern blot results of selected on RNA from HC11 mouse
mammary epithelial cells undergoing lactogenic differentiation in the
presence and absence of EGF. HC11 cells were grown as described in
Fig. 1A and then incubated in differentiation media containing
dexamethasone (10
−6M), insulin (5µg/ml) and prolactin (5µg/ml)
with or without EGF (10 ng/ml) for 0 or 72 h. RNAs were extracted
and used for Northern blot with the probes indicated. The blots were
hybridized to β-actin as a loading control
52 W. Wang et al.of proteins that are elevated in HC11 lactogenic differen-
tiation as Runx2-regulated in developing skeleton including
osteopontin, CTGF/CCN2, and CCCL9 (Hecht et al. 2007).
Like CTGF expression, osteopontin levels are high in
breast tumors that metastasize to the bone (Kang et al.
2003) (Carlinfante et al. 2003). If there is a connection
between the expression of these small secreted proteins and
the ability of metastatic breast tumors to target the bone
environment remains to be conclusively determined, but
they are readily transcriptionally activated in HC11 cells.
The secreted osteopontin protein is also widely detected in
plasma, urine and bile, and a recent study demonstrated that
it is present in human milk (Nagatomo et al. 2004). A
variety of stimuli, including phorbol 12-myristate 13-
acetate, 1,25-dihydroxyvitamin D, basic fibroblast growth
factor, tumor necrosis factor-α, interleukin-1, interferonγ
and lipopolysaccharide, elevated osteopontin expression.
However, whether osteopontin expression in HC11 cells is
due to dexamethasone, prolactin, or insulin is not estab-
lished, but osteopontin expression was enhanced by the
addition of EGF to the lactogenic hormone mix. Other
extracellular matrix proteins and proteins involved in tissue
reorganization are induced during lactogenic differentiation
of HC11 cells (Table 3). The list includes structural proteins
as well as proteases. In addition, an increase in expression
of Rac1 and ROCK were observed, relevant because a role
for Rac1 has been proposed in mammary epithelial cell
differentiation (Akhtar and Streuli 2006).
The regulation of key growth and cell cycle regulators
plays an important role in the HC11 differentiation
progression. Relative expression of cyclin D1 declines
along with that of the p18INK4. HC11 cells undergo
growth arrest during differentiation in part regulated by the
decrease in cyclin D1. There is a concurrent increase in
p21
CIP suggesting it is the potent cdk inhibitor contributing
to control of growth arrest in HC11 cells in this system.
While cyclin G2 increased following DIP-stimulation it is
likely that this is the result of glucocorticoid-mediated event
(Vedoy and Sogayar 2002). Our analysis detected alter-
ations in the regulation of IGFBP2 and IGFBP5 in HC11
cells undergoing lactogenic differentiation in agreement
with a previously reported finding (Phillips et al. 2003).
Lactogenic differentiation induced multiple gene tran-
scription events, while EGF blocked a number of these
processes. For example, during lactogenic differentiation,
the transcription element binding proteins (KLF4, KLF9)
were induced, but were inhibited by EGF. KLF9 has been
implicated as a transactivator of progesterone – and
estrogen-dependent transcription in endometrial epithelium,
another hormonal responsive tissue. (Velarde et al. 2007;
Zhang et al. 2003). This provided, in part, an explanation of
the large scale gene expression changes during lactogenic
differentiation that were blocked by EGF. Numerous
ribosomal protein transcripts were induced in both differ-
entiation and EGF blockage process, suggesting that these
genes are not a target of the mitogen-induced inhibition. In
conclusion, our data provide further insight into the signal
transduction pathways and gene interactions in the HC11
mouse mammary epithelial cell line during lactogenic
differentiation.
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